Last updated on December 2019

Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease


Brief description of study

The primary objective of this study is to evaluate the efficacy of filgotinib as compared to placebo in establishing combined fistula response at Week 24. Participants will have the option to enter a separate long-term extension study if they meet eligibility requirements.

Clinical Study Identifier: NCT03077412

Find a site near you

Start Over

Val R. Hansen, M.D.

Bountiful, UT United States
1.1miles
  Connect »